Article Details

GSK and Alector Collaborate on Neurodegenerative Disease mAb Candidates

Retrieved on: 2021-07-09 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

GSK and Alector Collaborate on Neurodegenerative Disease mAb Candidates. View article details on hiswai:

Excerpt

... to develop and commercialize two clinical-stage, potential first-in-class monoclonal antibodies (mAbs), AL001 and AL101, for the potential treatment ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up